Pharmaceutical Industry

Zafa is presently ranked at #2 (By selling more than 60 million unit packs per annum)

in Pakistan as per Unit Wise sales and is operating with Nine (9 manufacturing facilities and two (2) to be commissioned soon. Today ZAFA's product range represents a wide category of therapeutic classes and is one of the few companies in the world to manufacture Insulin formulations (both Hunman and Bovine). Product range includes more than 300 products with another 30 in the pipeline, While 13 of their products are leaders in Pakistan as per Unit Wise sales.

The management of Zafa has developed an internal quality audit plan to check the effectiveness of the command and control system and a cross facility team has been developed and trained to perform independent audits of different facilities within the group.

Other Unique features of Zafa

ZAFA Shorab Goth is our most modern and latest Pharmaceutical Formulation Facility. It is one of the largest facilities, area wise in Pakistan, built on an area of 170,000 square feet.
ZAFA Hormones Division is a dedicated facility for the manufacture of Hormonal products. It has been built on latest WHO and cGMP guidelines and is one of the few dedicated facilities operating around the world.
Zafa's BALSAM Pharmaceutical, is the largest Pharmaceutical manufacturing concern of Sudan and is located at North Khartoum Industrial region.

Topic of the Week
Got an Interview?

Your skills will be the foundation of the strategy you use to ‘sell’ yourself to employers as exactly the type of candidate they want.
Your strengths are part of yourself, the beliefs, values, principles, and the personal qualities that distinguish you as an individual.
Recognize your strengths and weaknesses. Assess your skills and you will identify your strengths.
Think about your accomplishments, the things you have done that gave you enjoyment, satisfaction and rewards.
Use the STAR technique: Situation or Task, Action you took, Results you achieved.
Make a list of about five to ten of your accomplishments; start each with an action verb and try to quantify the results as much as possible.
For example: Create, Develop, Solve, Implement, Lead, Organize, Improve, Sell, Direct etc. If so, How Much? How Many? How soon? Etc.
And what happened as a result? How did the Business or the Organization benefit?
When you have the list, ask yourself what the specific skills and strengths were that you used in order to make this happen. Do a frequency count of your most used strengths and skills.
These will tell you who you are, what you enjoyed the most, and what helped result in the most satisfying and rewarding accomplishments.



Articles Bits & Bytes Books & Authors City News Diplomatic Affairs Education Global Halal Expo Health Interviews Marketing Special Reports

Learn Pharmaceutical Marketing - Teach yourself Information Way of Success Tackle the Tough one first


Pfizer Animal Health Expands Global Commitment To A Safe Food Supply With A New Focus On Healthy Fish Acquires Canada-based Microtek, a Leading Researcher, Developer and Manufacturer of Vaccines for Global Aquaculture NEW YORK, N.Y., May 25 - Pfizer Animal Health today announced its acquisition of Microtek International, Inc., a recognized innovator in aquaculture vaccines, R&D and healthcare diagnostic services. The acquisition further expands Pfizer’s commitment to a safe food supply from healthy beef and dairy cattle, swine, poultry and, now, fish. Total global fish production – largely for human consumption – now exceeds that of pork, poultry, beef or dairy. Farmed fish production is becoming increasingly important in meeting global demand and is anticipated to account for 55% of total fish production by 2017, according to industry sources.“The time is right for Pfizer Animal Health to enter the global market for aquaculture healthcare therapeutics,” said Juan Ramón Alaix, president, Pfizer Animal Health. “The integration of Microtek R&D into Pfizer Animal Health also will allow us to build a more diverse and innovative portfolio in biopharmaceuticals. The meat, dairy, egg and fish products that people enjoy for healthy living begin with a healthy food animal.” William Kay, Ph.D., president and chief executive officer, Microtek, who will continue to serve Pfizer in a consultant role, said, “Microtek not only brings to Pfizer Animal Health industryleading vaccines and technology, but also complements Pfizer’s portfolio of health services and diagnostics for food animal production.” Terms of Pfizer Animal Health’s acquisition of Microtek were not disclosed.A growing Pfizer global commitment to safe food According to Mr. Alaix, during the last three years, Pfizer Animal Health has continued to expand its commitment to a safe food supply. In addition to acquiring last year a substantial portion of Wyeth/Fort Dodge Animal Health’s biological and pharmaceutical R&D, manufacturing and food animal products and services, Pfizer Animal Health also: Earlier this year, expanded into global, animal health generic medicines by acquiring R&D and a product line-up from Vetnex Animal Health Limited in India; In 2008, established Pfizer Animal Genetics, helping breeders focus on high-quality beef cattle production with genetic markers, by acquiring R&D and technology from Catapult Genetics, Pty., Ltd., in Australia, and Bovigen, LLC, in the U.S.;And in 2007, enhanced a growing Pfizer Poultry Health business by acquiring R&D and innovative in-ovo vaccination technology from Embrex, Inc, in the U.S.About Microtek Microtek International, Inc. is a privately-held company based in British Columbia, Canada, with commercialized vaccines across a number of fish species. Novel, efficient vaccine injection, oral or immersion delivery systems help to ensure long-term protection of disease in fish across Canada, the U.S., Chile, and parts of Europe. Microtek has a robust product pipeline focused on addressing unmet or underserved needs in farmed fish health. An extensive Microtek research network also includes alliances with leading universities in Canada, U.S. and in Europe. For more information, visit www.Microtek-Intl.com. About Pfizer Animal Health Pfizer, Inc. (NYSE: PFE), the world’s largest research-based biomedical and pharmaceutical company, also is a world leader in discovering and developing innovative animal vaccines and prescription medicines, investing an estimated $300 million annually. In the first quarter of 2010, Pfizer Animal Health generated revenue of $846 million, and for full-year 2009, $2.8 billion, including revenue from Wyeth/Fort Dodge since Pfizer’s acquisition in October.In addition to helping assure a safe, global food supply from healthy food animals, Pfizer Animal Health also helps dogs, cats and horses to live healthy longer. For additional information on Pfizer’s portfolio of animal products and services, visit www.PfizerAnimalHealth.com.
Zafa Pharmaceuticals Held a Lucky Draw at its Head Office Zafa Pharmaceuticals Pvt Ltd Pakistan's first multinational company is running a lucky draw scheme for trade level nowadays. In this connection a lucky draw held in its head office. Mr. Shakil Haroon chairman Pakistan chemists and druggists association central zone was the chief guest at this occasion.Mr. Jawad Md Zafa Pharma and his management team was also present. M. Jawad Ameen MD Zafa Pharam talking to Jeevey Pakistan team said that Zafa Pharma is holding 90% market ratio of oral family planning pills in Pakistan. Zafa Pharmaceutical is running its scheme for its Famila brand of birth controle. The chief Guest Mr. Shakil did the lucky draws for the fortunate winners. He also talked at this moment to Jeevey Pakistan and said that PCDA looks after the pharma business from top to bottom and praised Zafa's current activity as this kind of activity enhance the moral of traders and they take more interest in national cause of birth controle by participating the activity in this regard.
On 75% Medicine The consumer will have to pay the VAT - Zahid Saeed Zahid Saeed Indus pharma- 15-03-2010
PPMA seeks consistent pricing, import, vitamins policy KARACHI, Pakistan Pharmaceutical Manufacturers Association (PPMA) has urged the government to announce a long term "pricing policy", "import policy" and "vitamins policy" for pharmaceutical industry. Addressing a press conference here Tuesday, newly elected president PPMA, Mian Asad Shuja-ur-Rehman said that there is no pricing revision for drugs since 1991 and warned that the industry was will face a sluggish growth if prices are not revised upward. He said that local pharmaceutical industry was growing at a rate of 17 percent while pharma exports were progressing at 15 percent annually. He claimed that the share of local national pharmaceutical industry in the total medicine production has enhanced from 18 percent to more than 60 percent while the share of multinational companies (MNCs) has declined from 82 percent to 40 percent.He said that quality and standards of local national pharma industry were very high and therefore, they are producing drugs for several MNCs in the country."This growth can be reversed or stopped if prices are not reviewed", he said and added that Supreme Court of Pakistan has given a three-month time to the government to announce pricing policy for drugs.Similarly, he said that the government has to announce its import policy and vitamins policy for drugs so that local manufacturers should take decision on the basis of this framework.Rehman suggested that the government should not include those medicines in the import list which are being manufactured in the country by 20 to 25 local national companies. Only those drugs should be allowed for imports which are not manufactured locally.He pointed out that registration of new drugs was almost stopped as the "registration board" did not have a meeting for the past eight months. This has also badly affected the local national pharma industry as companies cannot begin production of new drug in Pakistan, he noted.Responding to a question about the allegation against local companies for producing spurious drugs, PPMA chairman said that less than "one percent" of the total drugs manufactures in Pakistan were fake or substandard.He said the Health Minister has assured the association that he will make a statement on the Floor of the House to clarify the wrong impression created against locally made medicines.Rehman said this allegation has not only tarnished the image of national pharma industry in the country but the buyers have also sought clarification from us on this issue. It might affect our local sale and exports as well, he added.PPMA chief said that drug prices were raised by 3.5 percent in 2001 and since than no price rise was allowed by the government. The price increase was allowed only in "hardship cases" between 2007 and 2008, he added.He said that during this period from 2001 to 2010, the prices of raw materials and other inputs including electricity, gas and petroleum prices has surged manifold. The devaluation of Pak rupee by more than 60 percent has also inflated raw material prices, he observed. Former Chairman PPMA Zahid Saeed, Dr Kaiser Waheed, Regional Chairman, Tariq Ikram, Haroon Qasim, Dr A Shakoor, Shahzeh Akram, Hamid Raza, Mian Nasir Liaquat and others were also present on the occasion. A Comprehensive Report on Afghanistan's Pharma Market By Mr. Zakiullah Khan GM Export Karachi, Mr. Irfan Baig Country Sales Manager Peshawer, Helix Pharma (Pvt) Karachi (19 - 24 Dec 2009) Dec 19, 2009. *Retail Market Survey* Areas: The Afghanan, Makrooyan, Karteparwan, Khairkhana, Shahr e Now, Hospital Pharmacies. Chemists Called: Nasir Darmaltoon, Nabi Shamshad Darmaltoon, Wase Darmaltoon, Basharat Darmaltoon, Mohsin Darmaltoon, *Doctor Visits* Dr. Yusuf “President Eye Association Afghanistan” Dr. Muhd. Reshad Sadiqyar Dr.Nazruddin Najam Dr. Muhd. Alam Qahir Dr. Najeebullah Toheedwal Meeting with “Helix’s Distributor” included, M/s Bait Nika Ltd. Kabul, Al-Kawsar Sherzay Ltd, Nabizada Pharma Co. Ltd. Jalalabad. Mr. Ghulam Rasool Gardez, Mr. Gulnawar Ghazni.(Mr. Haji Agha of Kandhar was not available due to performing of the hajj) Problems: Insufficient Literature, Giveaway, Poor Quality of master cartoons, Empty blisters & Eye drops, Training of Medical Representatives, Product expiry should be 2 years, Suggestions: Commercial stocks should be 200 units in each cartoon & Eye drops should be 400 units, Wall hangings, panafax, posters, product list or product guide, Zomax caps 6’s packing alu alu blister confirm order by dr. yousaf & ghulam rasool of 20000 units, Tear substitute Eye Drops, Ferollic packing change like Ironal 20000 packs order by dr. yousaf, Vision Vit of sante specially demanding by Eye Doctors, Special support of company in Doctors activities, Area code should be suggested only, *Meeting with Medical Representative of Helix.* Comments: We did very hard work for Helix & develop very well repute in Afghan Market. Helix has excellent product portfolio which is acceptable to Afghan doctors. Efficacy of the products has also been accepted. Helix can grow very well but it needs only competitive promotion. Dec 20, 2009. *Whole Sale Market Survey & Meetings with “other Distributors”* Markets: Qadir Bakhshi, Parwan Hotel, Sehat Market, Ilham Firdous, Shamshad, Indian, Irani, Chines, Bangladesh & Medical Equipments. *Meeting with other companies medical reps.* Companies are not implementing promotional policies just like Pakistan. Getz, Nabiqasim & multinational are implementing the same that why getting desire results. *Meeting with “Arian Asia Pharma Co. Ltd.” (Sole Agent Searle)* The Sales of Searle are 30 to 40 lacks per month new products are not selling. Searle is 16 year old company in Afghanistan but now a day they are losing their credibility in Afghan Market. *Meeting with “Bashir Tahir Saharzai Ltd Group of Kawser Asia+Afghan Tolo* *(Sole Agent Genix, Bosch, Z-Jan, Scottman, Biogenic, Highnoon, Willson, Werrick, Scottman.)* They are financially very sound. We have detailed our proposal with Mr. Naseem one of the important director of this company. He commit after the discussion with others directors of the company, he will come to Peshawar or Karachi to finalize the matter. *Visit to Ministry of Health Kabul* Advise by registration department of the Ministry of Public Health Kabul. “Helix should prepare their missing Drug Master Files other wise it may cause the cancellation of registered drugs” Dec 21, 2009. *Leading Hospital’s Visit* Al-Noor Eye Hospital, Bilsum Hospital, Rabia Balkhi Hospital, Indragandhi Hospital, Laisa Maryam *Meeting with “Rana Health Care” of Mr. Shahzad Haqqani* Rana Health care is a newly setup in Afghan Market. They are also working in professional manners. They can invest Rs. 10 millions although the Helix will start company parole promotion. Their detailed proposal also enclosed. Dec 22, 2009 *Meeting with “Alhaj Mualim Mangal Pharma Co. Ltd.”* *Distributor for Abbott, Getz, Merck, Pharmacia, Park Davis, Sandoz, Nabi Qasim, Serg, Scilife.* They are doing comparatively heavy work I mean working with very good sales Producing companies. At the moment they are not interested to hire new company For distribution. *Meeting with “Mr. Dost Muhammad” c/o Stalwart Pharmaceutical Peshawar.* He did not meet our criteria. *“Wiyar Safi Ltd.”Distributor for CCL* They are very hardworking people in Afghanistan. We have also detailed our proposal with Mr. Abduwali Director Marketing of the said company.s Comments: Our Chief Executive outside the country, I will discuss the proposal than meet with you in Karachi. Dec 23, 2009. *Market survey & Competitors Activities* Qadir Bakhshi, Parwan Hotel, Sehat Market, Ilham Firdous, Shamshad, Indian, Iranian, Chinese, Bangladesh, Turkish & Medical Equipments Companies Operating in Afghanistan Activity Ú Jalphar (UAE): Television, Refrigerator, Generator, Fans etc. Ú Ekseer (Iran): Laptop to every potential doctor. Ú Bayer (Pakistan): Cash. Ú Nabi Qasim (Pakistan): 10% Doctor discount. Ú Merck (Pakistan): Medical Books, Doctor’s Pads. Ú Searle (Pakistan): Medical Books, Doctor’s Pads. Ú Global (Pakistan): Computers, Television, Refrigerator, Fans etc. Ú Saydon (Pakistan): Shirts, Pants, coats, overalls & Hospital services. Ú Z-Jan (Pakistan): Open Market Discount & Doctor activity of 30% Ú Getz (Pakistan): Getz has started full fledged activities like Pakistan. Getz started foreign tours to potential doctors of Afghanistan from his launching. It seems that soon Getz Pharma will leave behind all the companies in Afghanistan. Ú Turkish Companies: Now a days Turkish companies seems in a good growing position. Most of the companies providing 10% cash payments to doctors. Along with cash they trying to oblige their customers both doctor & chemist. I am sending a few gifts of a newly launched MN Pharam Turkey. Ú Bangladeshi Companies: Most of the peoples like Bangla companies due to its economy and excellent packaging. Ú Chinese Companies: They are promoting by local promoters only on the basis of cash. Hospitals Strength Al-Noor Eye Hospital 40-50 Eye Drs. Bilsum Hospital 35-50 Gen.Drs. * Rabia Balkhi Hospital 20-25 Gyn. Drs. * Indragandhi Hospital 30-50 Paeds * Laisa Maryam Hospital 30-40 Gen.Drs. * Jamhoriat (Army) Hospital 50-80 Gen.Drs. * General Hospital (Ibne-Seena) 30-50 Gen.Drs Population Total : 40 millions 25 millions ( Citizens ) 15 millions ( Refugees ) Pharma Business $ 2000 millions $ 1200 millions (Importers) $ 800 millions ( NGO’s ) Therapeutic Segment Anti infective Analgesics & Antipyretics Respiratory System Gastro-intestinal System Dermatological System Nutrition Sensory System / Eye Products etc. Hospital Solutions Molecules Amoxicillin Clavulanic Acid Cefixime Cefatoxime Sodium Ceftriaxone Cephradine Azithromycin Ofloxacin Ciprofloxacin Levofloxacin Diclofenac Paracetamol Losartan Atorvastatin Iron-Polymaltose Resperido Omeparazole Zafa Pharmaceutical arranged a seminar on"Use of Noreithisterone in Gynecological disorders" Join ZAFA CLUB to serve the humanity. This club is basically for Proud Pakistani Doctors who believe in serving the country and think that every Human being / Every Pakistani has a right to live healthy life through easy access to medical facility just like ZAFA believes in "Medicine for all" All you have to do is send your information to Mr. Rashid Anwar , Business Unit Head at his cell 0333- 2321996 or email him at zafaph@cyber.net.pkThis is a free promotional activity of ZAFA & Jeevey Pakistan news website so that people could have an access to quality doctors for their medical issues. In this conection you can include your pics, clinic timing and information of free medical camps arranged at your clinics. ZAFA Pharmaceuticals Laboratories (Private) Limited Jeevey Pakistan has always focused such things which are the real signs of proud ness for Pakistan.In this connection we have chosen Pharmaceutical industry which is basically comprised of Multinationals and the local ones in common words. Jeevey Pakistan has selected a multinational Company to focus its those strengths which make Pakistan proud of it. The amazing thing is that this multinational company is not a foreign company working in Pakistan but it is a Pakistani company ZAFA Pharmaceuticals Laboratories (Private) Limited which is the 1st Pakistan Based Multinational Pharmaceutical Company, It was founded in 1973, by it's present Chairman and Chief Executive, Mr. Muhammad Amin Khan. Their founder firmly believes in the theory of "MEDICINES FOR ALL", which has played a key role in setting up the prices of their new introductions in the market. Zafa's motto is "NOBODY SHOULD SUFFER FROM WANT OFMEDICATION" As it's been mentioned earlier that ZAFA is the 1st Pakistan based Multinational Pharmaceutical manufacturing concern with its own manufacturing facility based in Khartoum Sudan. In addition to this they have presence in various African, Middle Eastern and South American countries. Zafa is an ISO 9001:2000 certified manufacturing concern and has emerged as a leading Pharmaceutical Group of Companies that has brought the concept of Dedicated Manufacturing facilities in Pakistan. Zafa is presently ranked at #2 (By selling more than 60 million unit packs per annum) in Pakistan as per Unit Wise sales and is operating with Nine (9 manufacturing facilities and two (2) to be commissioned soon. Today ZAFA's product range represents a wide category of therapeutic classes and is one of the few companies in the world to manufacture Insulin formulations (both Hunman and Bovine). Product range includes more than 300 products with another 30 in the pipeline, While 13 of their products are leaders in Pakistan as per Unit Wise sales. The management of Zafa has developed an internal quality audit plan to check the effectiveness of the command and control system and a cross facility team has been developed and trained to perform independent audits of different facilities within the group. Other Unique features of Zafa ZAFA Shorab Goth is our most modern and latest Pharmaceutical Formulation Facility. It is one of the largest facilities, area wise in Pakistan, built on an area of 170,000 square feet. ZAFA Hormones Division is a dedicated facility for the manufacture of Hormonal products. It has been built on latest WHO and cGMP guidelines and is one of the few dedicated facilities operating around the world. Zafa's BALSAM Pharmaceutical, is the largest Pharmaceutical manufacturing concern of Sudan and is located at North Khartoum Industrial region. Topic of the Week Got an Interview? Your skills will be the foundation of the strategy you use to ‘sell’ yourself to employers as exactly the type of candidate they want. Your strengths are part of yourself, the beliefs, values, principles, and the personal qualities that distinguish you as an individual. Recognize your strengths and weaknesses. Assess your skills and you will identify your strengths. Think about your accomplishments, the things you have done that gave you enjoyment, satisfaction and rewards. Use the STAR technique: Situation or Task, Action you took, Results you achieved. Make a list of about five to ten of your accomplishments; start each with an action verb and try to quantify the results as much as possible. For example: Create, Develop, Solve, Implement, Lead, Organize, Improve, Sell, Direct etc. If so, How Much? How Many? How soon? Etc. And what happened as a result? How did the Business or the Organization benefit? When you have the list, ask yourself what the specific skills and strengths were that you used in order to make this happen. Do a frequency count of your most used strengths and skills. These will tell you who you are, what you enjoyed the most, and what helped result in the most satisfying and rewarding accomplishments.